These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 2417048)

  • 1. Central alpha-adrenergic agonists in chronic heart failure and ischemic heart disease.
    Giles TD; Thomas MG; Sander GE; Quiroz AC
    J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S51-5. PubMed ID: 2417048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute and chronic effects of bunazosin in patients with congestive heart failure].
    Kawahara Y; Hasegawa K; Sawayama T; Nezuo S; Inoue S; Tadaoka S
    Kokyu To Junkan; 1989 May; 37(5):529-33. PubMed ID: 2568669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-adrenergic mechanisms in the pathophysiology of left ventricular heart failure--an analysis of their role in systolic and diastolic dysfunction.
    Giles TD; Sander GE; Thomas MG; Quiroz AC
    J Mol Cell Cardiol; 1986 Nov; 18 Suppl 5():33-43. PubMed ID: 2879938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonists.
    Packer M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S38-43. PubMed ID: 2478808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and neurohumoral responses to dynamic exercise: normal subjects versus patients with heart disease.
    Francis GS
    Circulation; 1987 Dec; 76(6 Pt 2):VI11-7. PubMed ID: 2890448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
    Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
    J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
    Kawahara Y; Hasegawa K; Sawayama T; Inoue S; Nakamura T; Kakumae S; Tadaoka S; Nakao M; Nezuo S
    Kokyu To Junkan; 1989 Dec; 37(12):1333-40. PubMed ID: 2575781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic mechanisms in congestive heart failure.
    Andersson KE
    Acta Med Scand Suppl; 1986; 707():37-44. PubMed ID: 2874691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of functional capacity and survival in congestive heart failure. Effects of activation of the sympathetic nervous system.
    Packer M
    Postgrad Med; 1988 Feb; Spec No():96-103. PubMed ID: 2894667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ; Davies MK
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrinology of cardiac failure. Pathophysiologic aspects--hemodynamics.
    Persson S
    Acta Med Scand Suppl; 1986; 707():7-14. PubMed ID: 2943144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers in hypertensive and coronary heart disease.
    Goldstein S
    Arch Intern Med; 1996 Jun; 156(12):1267-76. PubMed ID: 8651834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further characterization of putative alpha--adrenergic receptors in brain that affect blood pressure and the secretion of ACTH, GH and renin in dogs.
    Ganong WF; Chalett J; Jones H; Kaplan SL; Karteszi M; Stith RD; Van de Kar LD
    Endocrinol Exp; 1982 Nov; 16(3-4):191-205. PubMed ID: 6129126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
    Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.